Clinical Study Results
Research Sponsor: MedImmune, a wholly owned subsidiary of AstraZeneca
Drug Studied: Cotadutide
Study Title: A study to learn how much cotadutide got into the blood when injected into different parts of the body in healthy participants
Protocol Number: D5670C00025

Thank you!
Thank you for taking part in the clinical study for the study drug cotadutide, also called MEDI0382.
AstraZeneca sponsored this study and believes it is important to share the results. An independent non-profit organization called CISCRP helped prepare this summary of the study results for you.
If you participated in the study and have questions about the results, please speak with the study doctor or staff at your study site.